Skip to content

Case Study: Parkinson's Disease Modeling

This case study shows how Ncardia developed a Parkinson's disease model from iPSC-derived neurons and astrocytes.
TAKE THE FIRST STEP
Case Study- Parkinson_s Disease Modeling
Parkinson’s disease modeling by over-expression of alpha-synuclein pre-formed fibrils

Parkinson’s disease (PD) is a neurodegenerative condition characterized by progressive shaking, stiffness, and difficulty with walking, balance, and coordination. Misfolding and aggregation of α-synuclein proteins is believed to drive neurodegeneration in PD.

hiPSC-derived neurons that recapitulate these typical pathological features provide an exciting system for PD modeling, which can be utilized for the investigation of disease pathogenesis and to provide specific and valuable readouts for drug discovery.

This case study shows how Ncardia successfully created a PD model with our Ncyte CNS cells, to enable assessment of alpha-synuclein pre-formed fibril-induced toxicity. In a later stage, this disease model was used for phenotype rescue upon compound treatment.




ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the case study by
filling out the form below: